Six years since our first investment in Intensity Therapeutics, VCapital is invested in eleven companies today. Having reached our middle age in “venture capital years,” we are growing increasingly optimistic about our prospects for ultimate maturity.
Author Archives: VCapital Team
Some Baseballisms for A New Year
With 2021 on deck, our thoughts turn to baseball. Spring training is less than two months away and we hope the pandemic is finally in the bottom of the ninth.
Cleversafe’s home run team batting again with Ocient
Cleversafe’s exit, selling to IBM for $1.3 billion, took place in 2015, just as VCapital was starting up. A big idea intersected with practical need and market demand. Many new millionaires were minted as a result.
Venture Capital in a Time of Historic Change
The pandemic’s end remains unknown. Sharing our thoughts on COVID implications for the economy, and especially for venture capital investment, seems in order.
The LoPresti Family: Founders, Investors, and Philanthropists
VCapital is humbled to think of our decade-long relationship with the LoPresti family, as both investors and as friends.
Diversify Differently: What the Heck Does THAT Mean??
Investors most certainly turn to venture capital for investment home runs. We urge our VCapital investors to diversify their entire portfolio both with — and within — the venture capital asset class.
Raydiant Oximetry leaders know how to make it happen.
In the venture capital world, the jockey is often more important than the horse. We look for leader-managers who have proven they can make things happen.
Keeping you informed about your investments.
Our plan is to communicate to you what is most relevant to your relationship with VCapital and your investments.